DASATINIB Spirig HC cpr pell 50 mg 60 pce
7680695980028
CH-69598
L01EA02
07.16.1.
Reimbursement limitations:
SPRYCEL2
Ce dosage est exclu pour le traitement de patients souffrant de leucémie myéloïde chronique à …
1 / 3
google
Details
- Product number
- 6959802
- CPT
- -
- Packaging group
- 60
- Unit
- Tablette(n)
- Composition
- Filmtablette: dasatinibum 50.00 mg, lactosum monohydricum 67.50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.68 mg, E 171, triacetinum, pro compresso obducto.
Articles (1)
Dasatinib Spirig HC 50 mg, Filmtabletten
Filmtabletten
60
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
67.5 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
0.36 MG | Substance | HBESI |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
1.68 MG | Substance | HBESI |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1183.10
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69598
- Drug name
- Dasatinib Spirig HC, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/02/2024
- Authorization expiration date
- 21/02/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DASATINIB Spirig HC cpr pell 50 mg 60 pce
- Description (DE)
- DASATINIB Spirig HC Filmtabl 50 mg 60 Stk
- Market launch
- 22/02/2024
- Narcotic (BTM)
- No